Key terms

About CDTX

Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest CDTX news

Yesterday 9:48am ET Cidara Therapeutics rating placed under review at H.C. Wainwright by TipRanks Yesterday 6:20am ET Wall Street Analysts Are Bullish on Top Healthcare Picks by TipRanks Apr 24 4:25pm ET Cidara Therapeutics Refocuses Strategy with Asset Sale by TipRanks Apr 24 4:24pm ET Cidara Therapeutics: Strategic Partnerships and Governance Changes by TipRanks Apr 24 4:13pm ET Cidara Therapeutics reacquires rights to CD388 from Johnson & Johnson for $85M by TipRanks Apr 24 4:03pm ET Cidara Therapeutics divests rezafungin to Mundipharma by TipRanks Apr 24 10:53am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Apr 24 2:00am ET Cidara Therapeutics’ Restatement Woes: Costs, Distractions, and Investor Confidence on the Line by TipRanks Apr 23 7:50pm ET Cidara Therapeutics trading halted, news pending by TipRanks Apr 22 5:13pm ET Cidara Therapeutics reports Q4 EPS (4c), consensus (10c) by TipRanks Apr 22 5:08pm ET Cidara Therapeutics discloses Nasdaq listing deficiency notice by TipRanks Apr 22 8:55am ET Cidara Therapeutics announces 1-for-20 reverse stock split by TipRanks Apr 08 10:45am ET Buy Rating Affirmed for Cidara Therapeutics Amid Promising Oncology Program Developments by TipRanks Feb 12 8:06am ET Cidara Therapeutics receives $11.14M milestone payment from Mundipharma by TipRanks Feb 10 4:05am ET Cidara Therapeutics Granted Nasdaq Listing Extension by TipRanks Jan 29 4:48pm ET Cidara spikes 20% after MHRA approval of Rezzayo for invasive candidiasis by TipRanks Jan 29 4:40pm ET Cidara gets $2.8M milestone payment from Mundipharma for MHRA’s Rezzayo approval by TipRanks Jan 29 4:37pm ET MHRA approves Cidara Therapeutics’ Rezzayo for invasive candidiasis in adults by TipRanks

No recent press releases are available for CDTX

CDTX Financials

1-year income & revenue

Key terms

CDTX Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

CDTX Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Student demonstrators occupy the pro-Palestinian "Gaza Solidarity Encampment" on the West Lawn of Columbia University on April 24, 2024 in New York City.
Michael M. Santiago/Getty Images
What the pro-Palestinian protesters on college campuses actually want
People walk by the New York Stock Exchange (NYSE) on March 20, 2024 in New York City. The Dow was up slightly in late morning trading as traders analyze the Federal Reserve's latest decision on interest rates.
Spencer Platt/Getty Images
Stagflation fears just hit Wall Street. Now for the next crucial report on prices
Meta headquarters pictured on February 02, 2023 in Menlo Park, California.
Justin Sullivan/Getty Images
Meta’s stock plunges 15% on ‘aggressive’ AI spending plans
GettyImages-1159438448 copy.jpg
Lyndon Stratford/iStockphoto/Getty Images
Americans are falling behind on their payments